Effects of charcoal hemoperfusion with prostacyclin on the coagulation-fibrinolysis system and platelets of patients with fulminant hepatic failure--preliminary observations.
作者信息
Cordopatri F, Boncinelli S, Marsili M, Lorenzi P, Fabbri L P, Paci P, Salvadori M, Morfini M, Cinotti S, Casparini P
出版信息
Int J Artif Organs. 1982 Jul;5(4):243-7.
PMID:6749697
Abstract
摘要
相似文献
1
2
Prostacyclin to prevent platelet activation during charcoal haemoperfusion in fulminant hepatic failure.
Lancet. 1980 Jan 26;1(8161):173-5. doi: 10.1016/s0140-6736(80)90661-3.
3
Prostacyclin in haemodialysis and charcoal haemoperfusion.
Contrib Nephrol. 1983;36:68-72. doi: 10.1159/000407582.
4
Prostacyclin eliminates the bioincompatibility of charcoal haemoperfusion.
Proc Eur Dial Transplant Assoc. 1979;16:225-31.
5
Use of prostacyclin in extracorporeal circulation.
Int J Artif Organs. 1985 Nov;8(6):297-300.
6
Prostacyclin eliminates the thrombocytopenia associated with charcoal hemoperfusion and minimizes heparin and fibrinogen consumption.
Artif Organs. 1980 Aug;4(3):176-9. doi: 10.1111/j.1525-1594.1980.tb03930.x.
7
Artificial liver support in fulminant hepatic failure.
Bull N Y Acad Med. 1975 Apr;51(4):508-18.
8
Haemoperfusion through activated charcoal in dogs with fulminant liver failure.
Digestion. 1980;20(1):22-30. doi: 10.1159/000198410.
9
Effects of hemoperfusion rate and time of initiation of ACAC charcoal hemoperfusion on the survival of fulminant hepatic failure rats.
Trans Am Soc Artif Intern Organs. 1978;24:243-5.
10
The use of prostacyclin, PGI2, in the prevention of platelet aggregation during charcoal haemoperfusion.
Int J Artif Organs. 1979 Jul;2(4):207-10.
Zotero 插件